[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-346089-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-346089-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","nrf2-mediated-ferroptosis-suppression-defines-a-cancer-specific-vulnerability-in-tumors","NRF2-mediated ferroptosis suppression defines a cancer-specific vulnerability in tumors","","NRF2 is a master regulator of redox and metabolic homeostasis that protects normal tissues from stress but is frequently exploited by cancers to sustain survival and therapy resistance. Although NRF2 is dispensable for normal tissue function, its role within the native tumor microenvironment remains unclear. This study uncovers an essential tumor-specific dependency on NRF2 using a Kras-driven lung cancer mouse model, where NRF2 deletion eradicates cancer cells, reduces tumor burden, and prolongs survival by inducing in vivo ferroptosis, without exogenous inducers.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/nrf2-mediated-ferroptosis-suppression-defines-a-cancer-specific-vulnerability-in-tumors/346089/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/nrf2-mediated-ferroptosis-suppression-defines-a-cancer-specific-vulnerability-in-tumors/346089.png","ImageObject",300,407,{"name":42,"@type":43},"Theodora","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-15","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What discovery does the study report about NRF2 in tumors?","Question",{"text":63,"@type":64},"NRF2 deletion reveals an essential, previously unrecognized tumor-specific dependency on NRF2 for cancer cell survival in the tumor microenvironment.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does NRF2 deletion affect tumor outcomes in the mouse model?",{"text":68,"@type":64},"NRF2 deletion alone eradicates cancer cells, reduces tumor burden, and prolongs survival without pharmacologic intervention.",{"name":70,"@type":61,"acceptedAnswer":71},"What mechanism links NRF2 loss to cancer cell elimination?",{"text":72,"@type":64},"NRF2 deletion induces ferroptosis, shown by induction of canonical ferroptotic genes and protein markers in vivo within established tumors.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},346089,1790126420,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":55,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":113,"preview_page_count":33,"preview_urls":145},687197207919,"https://ap-avatar.wpscdn.com/avatar/a000253d6f5f7c60be?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779446848396160552","Redox Biology 96 (2026) 104352  \nContents lists available at ScienceDirect  \nRedox Biology  \njournal [homepage:](homepage: www.elsevier.com/locate/redox)[ www.elsevier.com/locate/redox](homepage: www.elsevier.com/locate/redox)  \nNRF2-mediated ferroptosis suppression defines a cancer-specific vulnerability in tumors  \nDichun Huang a,b, Mae Zhang a, Ben N. Stansfield a,c, Mona Ahmed d , Tianbao Xud, Lewis Alexander a,e, Annadurai Anandhan b , Mengjiao Mab, Pengfei Liu f,  \nYang Yang-Hartwich g, Deyu Fangh, Eli Chapman a,e,i, Joe G.N. Garcia a , Pak Kin Wong d, Aikseng Ooia,j, Donna D. Zhang a,i,k,*   \na Department of Molecular Medicine, Center for Inflammation Science and Systems Medicine, UF Scripps Institute for Biomedical Innovation and Technology, Jupiter, FL, USA  \nb Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ, USAc Genetics Graduate Interdisciplinary Program, University of Arizona, Tucson, AZ, USA  \nd Department of Biomedical Engineering, The Pennsylvania State University, University Park, PA, USA e Department of Pharmacology and Therapeutics, College of Medicine, University of Florida, Gainesville, FL, USA  \nf International Joint Research Center on Cell Stress and Disease Diagnosis and Therapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China g Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine, New Haven, CT, USA  \nh Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA i University of Florida Health Cancer Center, University of Florida, Gainesville, FL, USA  \nj Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA k Department of Medicinal Chemistry, University of Florida, Gainesville, FL, 32610, USA  \nA B S T R A C T  \nNRF2 is a master regulator of redox and metabolic homeostasis that protects normal tissues from stress but is frequently hijacked by cancers to sustain survival and therapy resistance. Although NRF2 is dispensable for normal tissue function, its role in maintaining cancer cells within the native tumor microenvironment has remained undefined. Here, we uncover an essential and previously unrecognized tumor-specific dependency on NRF2. Using an inducible KrasFSF.G12D/+ ;Nrf2Fl/Fl; Rosa26CreERT2/CreERT2 (KNR) mouse lung cancer model, we demonstrate that NRF2 deletion alone, without pharmacologic intervention, eradicates cancer cells, reduces tumor burden, and prolongs survival. Single-cell RNA sequencing coupled with artificial intelligence–based genotype classification revealed that NRF2-deleted cancer cells are selectively eliminated, whereas non-cancerous cells tolerate NRF2 loss. Mechanistically, NRF2 deletion induces ferroptosis, a regulated irondependent cell death pathway, evidenced by induction of canonical ferroptotic genes (Ptgs2, Acsl4, Tfrc) and protein markers (SO2/3-PRDX3, COX2, TfR1). Importantly, these data support that NRF2 loss induces ferroptotic cell death in vivo within established tumors, in the absence of exogenous ferroptosis inducers or external stress. These findings establish that cancer cells depend on NRF2 to suppress intrinsic ferroptotic stress for survival, a dependency not shared by normal tissues. This discovery fundamentally redefines the pathological role of NRF2 and positions NRF2 inhibition as a standalone, tumor-selective therapeutic strategy to eliminate Kras-driven malignancies by unleashing ferroptosis.  \n1. Introduction  \nNRF2 is a transcription factor that orchestrates cellular defense mechanisms against oxidative stress, proteotoxicity, metabolic dysregulation, and iron-overload by activating a set of antioxidant response element (ARE)-bearing genes [1–3]. In normal tissues, NRF2 is ubiquitously expressed but maintained at low basal levels through its interaction with KEAP1, which directs NRF2 for ubiquitination and subsequent degradation","cbCaijypi6raTJpA","https://ap.wps.com/l/cbCaijypi6raTJpA","pdf",11088336,"English","# Abstract\n# 1. Introduction","[{\"question\":\"What discovery does the study report about NRF2 in tumors?\",\"answer\":\"NRF2 deletion reveals an essential, previously unrecognized tumor-specific dependency on NRF2 for cancer cell survival in the tumor microenvironment.\"},{\"question\":\"How does NRF2 deletion affect tumor outcomes in the mouse model?\",\"answer\":\"NRF2 deletion alone eradicates cancer cells, reduces tumor burden, and prolongs survival without pharmacologic intervention.\"},{\"question\":\"What mechanism links NRF2 loss to cancer cell elimination?\",\"answer\":\"NRF2 deletion induces ferroptosis, shown by induction of canonical ferroptotic genes and protein markers in vivo within established tumors.\"}]","NRF2-mediated ferroptosis suppression defines a cancer-specific vulnerability in tumors | PDF",1790060036,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b33f8d07e431a872d46695a81b53068a.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c4143575204871d3523afd5a558eea5f.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d333a93597aef0ae641ba6cd8cd8e203.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8918584969754d173a76bc6b76ac535a.webp",980,1306]